Detalhe da pesquisa
1.
IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Cell
; 141(4): 717-27, 2010 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20478260
2.
Ex vivo tissue modelling informs drug selection for rare cancers.
Int J Cancer
; 154(7): 1158-1163, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38059815
3.
Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Nano Lett
; 20(3): 1637-1646, 2020 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32013452
4.
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
Int J Mol Sci
; 22(13)2021 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201655
5.
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.
Int J Cancer
; 147(8): 2176-2189, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249419
6.
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy.
Int J Mol Sci
; 21(19)2020 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992658
7.
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
Lancet Oncol
; 20(7): 961-971, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171444
8.
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Lancet Oncol
; 20(7): e378-e389, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267972
9.
Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery.
Biomacromolecules
; 20(5): 2148-2158, 2019 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995832
10.
Liquid biomarkers in melanoma: detection and discovery.
Mol Cancer
; 17(1): 8, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343260
11.
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.
Int J Cancer
; 142(9): 1926-1937, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29210065
12.
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms.
Mamm Genome
; 29(11-12): 866-878, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29968076
13.
Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma.
Cancer
; 123(S11): 2118-2129, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543695
14.
The Role of Sumoylation in Senescence.
Adv Exp Med Biol
; 963: 215-226, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197915
15.
Correction to Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Nano Lett
; 21(22): 9834, 2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726061
16.
Single-cell RNA sequencing in melanoma: what have we learned so far?
EBioMedicine
; 100: 104969, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38241976
17.
PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma.
Oncogenesis
; 13(1): 9, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418838
18.
Checkpoint kinase 1 inhibitor + low-dose hydroxyurea efficiently kills BRAF inhibitor- and immune checkpoint inhibitor-resistant melanomas.
Pigment Cell Melanoma Res
; 37(1): 45-50, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614154
19.
Membrane and cytoplasmic marker exchange between malignant neoplastic cells and fibroblasts via intermittent contact: increased tumour cell diversity independent of genetic change.
J Pathol
; 228(4): 495-505, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22692803
20.
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.
J Invest Dermatol
; 143(7): 1246-1256.e8, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736995